Natus Medical (BABY) Tops Q1 EPS by 4c

Natus Medical (NASDAQ: BABY) reported Q1 EPS of $0.09, $0.04 better than the analyst estimate of $0.05. Revenue for the quarter came in at $114.8 million versus the consensus estimate of $113.3 million.

GUIDANCE:

Natus Medical sees Q2 2019 EPS of $0.25-$0.32, versus the consensus of $0.34. Natus Medical sees Q2 2019 revenue of $121-125 million, versus the consensus of $125.1 million.

Natus Medical sees FY2019 EPS of $1.17-$1.44, versus the consensus of $1.28. Natus Medical sees FY2019 revenue of $489-505 million, versus the consensus of $498.91 million.

For earnings history and earnings-related data on Natus Medical (BABY) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
• Wendy's U.S. president to resign, company to create COO role